<unk>  is an immunological agent that is FDA approved for the prophylaxis of organ rejection in adult patients receiving a kidney transplant. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, and leukopenia.
Belatacept
Abatacept
Adalimumab
Ocrelizumab
Nebacumab
Atezolizumab
Efalizumab
Ibalizumab